CD274 and chronic myelogenous leukemia, BCR-ABL1 positive: revealed that the inhibition of differentiation of dendritic cells in the hematopoietic microenvironment, as well as the up-regulation of immune checkpoint expression such as PD-L1, were responsible for the impairment of CML immune function (23).